Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52024XC04646

    Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2024 to 30 June 2024 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)

    PUB/2024/703

    OJ C, C/2024/4646, 31.7.2024, ELI: http://data.europa.eu/eli/C/2024/4646/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    ELI: http://data.europa.eu/eli/C/2024/4646/oj

    European flag

    Official Journal
    of the European Union

    EN

    C series


    C/2024/4646

    31.7.2024

    Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2024 to 30 June 2024

    (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council  (1) or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council  (2) )

    (C/2024/4646)

    Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

    Date of the decision

    Name of the medicinal product

    INN (International Non-Proprietary Name)

    Holder of the marketing authorisation

    Number of the entry in the Community Register

    Pharmaceutical form

    ATC code (Anatomical Therapeutic Chemical Code)

    Date of notification

    3.6.2024

    Fluenz

    Influenza vaccine (live attenuated, nasal)

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/24/1816

    Nasal spray, suspension

    J07BB03

    4.6.2024

    17.6.2024

    ALTUVOCT

    efanesoctocog alfa

    Swedish Orphan Biovitrum AB (publ)

    112 76 Stockholm, Sverige

    EU/1/24/1824

    Powder and solvent for solution for injection

    B02BD02

    18.6.2024

    17.6.2024

    Sirturo

    bedaquiline

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/13/901

    Tablet

    J04AK05

    18.6.2024

    17.6.2024

    Truqap

    capivasertib

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/24/1820

    Film-coated tablet

    L01EX27

    18.6.2024

    20.6.2024

    FRUZAQLA

    fruquintinib

    Takeda Pharmaceuticals International AG Ireland Branch

    Block 2 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

    EU/1/24/1827

    Capsule, hard

    L01EK

    25.6.2024

    20.6.2024

    Tofidence

    tocilizumab

    Biogen Netherlands B.V.

    Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

    EU/1/24/1825

    Concentrate for solution for infusion

    L04AC07

    21.6.2024

    20.6.2024

    Wezenla

    Ustekinumab

    Amgen Technology (Ireland) UC

    Pottery Road, Dun Laoghaire, Co. Dublin, Ireland

    EU/1/24/1823

    Concentrate for solution for infusion

    Solution for injection

    Solution for injection in a pre-filled syringe

    L04AC05

    22.6.2024

    27.6.2024

    Eribulin Baxter

    eribulin

    Baxter Holding B.V.

    Kobaltweg 49, 3542 CE Utrecht, Nederland

    EU/1/24/1819

    Solution for injection

    L01XX41

    1.7.2024

    27.6.2024

    JERAYGO

    aprocitentan

    Idorsia Pharmaceuticals Deutschland GmbH

    Marie-Curie-Strasse 8, 79539 Loerrach, Deutschland

    EU/1/24/1818

    Film-coated tablet

    C02KN01

    28.6.2024

    27.6.2024

    Obgemsa

    Vibegron

    PIERRE FABRE MEDICAMENT

    Les Cauquillous, 81500 Lavaur, France

    EU/1/24/1822

    Film-coated tablet

    G04BD15

    28.6.2024

    27.6.2024

    Rybrevant

    amivantamab

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/21/1594

    Concentrate for solution for infusion

    L01FX18

    28.6.2024

    28.6.2024

    IXCHIQ

    Chikungunya vaccine (live)

    Valneva Austria GmbH

    Campus Vienna Biocenter 3, 1030 Wien, Österreich

    EU/1/24/1828

    Powder and solvent for solution for injection

    Pending

    28.6.2024

    Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

    Date of the decision

    Name of the medicinal product

    Holder of the marketing authorisation

    Number of the entry in the Community Register

    Date of notification

    6.6.2024

    Alecensa

    Roche Registration GmbH

    Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

    EU/1/16/1169

    7.6.2024

    6.6.2024

    Cinqaero

    Teva B.V.

    Swensweg 5, 2031 GA Haarlem, Nederland

    EU/1/16/1125

    11.6.2024

    6.6.2024

    Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

    KRKA d d., Novo mesto

    Šmarješka cesta 6, 8501 Novo mesto, Slovenija

    EU/1/17/1263

    17.6.2024

    6.6.2024

    Fasenra

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/17/1252

    7.6.2024

    6.6.2024

    Lymphoseek

    Navidea Biopharmaceuticals Europe Ltd.

    Kilminion South, Ballinroad, Dungarvan, Co. Waterford, X35 WP70, Ireland

    EU/1/14/955

    7.6.2024

    6.6.2024

    Pedmarqsi

    Norgine B.V.

    Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland

    EU/1/23/1734

    7.6.2024

    6.6.2024

    Ritonavir Mylan

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/17/1242

    7.6.2024

    6.6.2024

    Suliqua

    Sanofi Winthrop Industrie

    82 avenue Raspail, 94250 Gentilly, France

    EU/1/16/1157

    7.6.2024

    6.6.2024

    Sunlenca

    Gilead Sciences Ireland UC

    Carrigtohill, County Cork, T45 DP77, Ireland

    EU/1/22/1671

    7.6.2024

    6.6.2024

    Synflorix

    GlaxoSmithKline Biologicals S.A.

    rue de l'Institut 89, 1330 Rixensart, Belgique

    EU/1/09/508

    10.6.2024

    6.6.2024

    Tepmetko

    Merck Europe B.V.

    Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

    EU/1/21/1596

    10.6.2024

    6.6.2024

    Twynsta

    Boehringer Ingelheim International GmbH

    Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

    EU/1/10/648

    17.6.2024

    6.6.2024

    Veltassa

    Vifor Fresenius Medical Care Renal Pharma France

    100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France

    EU/1/17/1179

    7.6.2024

    10.6.2024

    AMGLIDIA

    AMMTeK

    8 rue campagne première, 75014 Paris, France

    EU/1/18/1279

    12.6.2024

    10.6.2024

    Ozempic

    Novo Nordisk A/S

    Novo Allé, 2880 Bagsvaerd, Danmark

    EU/1/17/1251

    11.6.2024

    10.6.2024

    Respreeza

    CSL Behring GmbH

    Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland

    EU/1/15/1006

    26.6.2024

    10.6.2024

    Wegovy

    Novo Nordisk A/S

    Novo Allé, 2880 Bagsvaerd, Danmark

    EU/1/21/1608

    11.6.2024

    13.6.2024

    Atazanavir Viatris

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1091

    14.6.2024

    13.6.2024

    Darunavir Viatris

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1140

    14.6.2024

    13.6.2024

    Inbrija

    Acorda Therapeutics Ireland Limited

    10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland

    EU/1/19/1390

    14.6.2024

    13.6.2024

    Lopinavir/Ritonavir Viatris

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/15/1067

    14.6.2024

    13.6.2024

    Ritonavir Viatris

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/17/1242

    14.6.2024

    13.6.2024

    TALVEY

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/23/1748

    14.6.2024

    13.6.2024

    TECVAYLI

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/22/1675

    14.6.2024

    13.6.2024

    Telmisartan Actavis

    Actavis Group PTC ehf.

    Dalshraun 1, 220 Hafnarfjörður, Íceland

    EU/1/10/639

    14.6.2024

    17.6.2024

    Eviplera

    Gilead Sciences Ireland UC

    Carrigtohill, County Cork, T45 DP77, Ireland

    EU/1/11/737

    18.6.2024

    17.6.2024

    Forxiga

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/12/795

    18.6.2024

    17.6.2024

    Galafold

    Amicus Therapeutics Europe Limited

    Block 1, Blanchardstown Corporate Park, Ballycoolin Road, Blanchardstown, Dublin D15 AKK1, Ireland

    EU/1/15/1082

    19.6.2024

    17.6.2024

    Giotrif

    Boehringer Ingelheim International GmbH

    Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

    EU/1/13/879

    18.6.2024

    17.6.2024

    Givlaari

    Alnylam Netherlands B.V.

    Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland

    EU/1/20/1428

    18.6.2024

    17.6.2024

    Kinpeygo

    STADA Arzneimittel AG

    Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

    EU/1/22/1657

    20.6.2024

    17.6.2024

    Mektovi

    Pierre Fabre Médicament

    Les Cauquillous, 81500 Lavaur, France

    EU/1/18/1315

    18.6.2024

    17.6.2024

    Pioglitazone Actavis

    Actavis Group PTC ehf.

    Dalshraun 1, 220 Hafnarfjörður, Íceland

    EU/1/12/755

    18.6.2024

    17.6.2024

    Rasagiline Viatris

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1090

    18.6.2024

    17.6.2024

    Renagel

    Sanofi B.V.

    Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

    EU/1/99/123

    19.6.2024

    17.6.2024

    Verzenios

    Eli Lilly Nederland B.V.

    Papendorpseweg 83, 3528 BJ Utrecht, Nederland

    EU/1/18/1307

    18.6.2024

    17.6.2024

    Vfend

    Pfizer Europe MA EEIG

    Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België

    EU/1/02/212

    18.6.2024

    17.6.2024

    Xultophy

    Novo Nordisk A/S

    Novo Allé, 2880 Bagsvaerd, Danmark

    EU/1/14/947

    19.6.2024

    17.6.2024

    Yentreve

    Eli Lilly Nederland B.V.

    Papendorpseweg 83, 3528 BJ Utrecht, Nederland

    EU/1/04/280

    18.6.2024

    17.6.2024

    Zometa

    Phoenix Labs Unlimited Company

    Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, County Meath, Ireland

    EU/1/01/176

    18.6.2024

    20.6.2024

    Abecma

    Bristol-Myers Squibb Pharma EEIG

    Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

    EU/1/21/1539

    26.6.2024

    20.6.2024

    Abiraterone Mylan

    Mylan Ireland Limited

    Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

    EU/1/21/1571

    21.6.2024

    20.6.2024

    Bridion

    Merck Sharp & Dohme B.V.

    Waarderweg 39, 2031 BN Haarlem, Nederland

    EU/1/08/466

    24.6.2024

    20.6.2024

    Cinacalcet Accordpharma

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

    EU/1/20/1429

    21.6.2024

    20.6.2024

    CONTROLOC Control

    Takeda GmbH

    Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

    EU/1/09/515

    25.6.2024

    20.6.2024

    Cymbalta

    Eli Lilly Nederland B.V.

    Papendorpseweg 83, 3528 BJ Utrecht, Nederland

    EU/1/04/296

    25.6.2024

    20.6.2024

    Duloxetine Lilly

    Eli Lilly Nederland B.V.

    Papendorpseweg 83, 3528 BJ Utrecht, Nederland

    EU/1/14/972

    24.6.2024

    20.6.2024

    Ifirmacombi

    KRKA d d., Novo mesto

    Šmarješka cesta 6, 8501 Novo mesto, Slovenija

    EU/1/11/673

    26.6.2024

    20.6.2024

    Kesimpta

    Novartis Ireland Limited

    Vista Building, Elm Park, Merrion Road, Ballsbridge, Dublin 4, Ireland

    EU/1/21/1532

    21.6.2024

    20.6.2024

    Livmarli

    Mirum Pharmaceuticals International B.V.

    Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

    EU/1/22/1704

    21.6.2024

    20.6.2024

    Ocrevus

    Roche Registration GmbH

    Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

    EU/1/17/1231

    21.6.2024

    20.6.2024

    Olanzapine Mylan

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/08/475

    21.6.2024

    20.6.2024

    PANTOZOL Control

    Takeda GmbH

    Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

    EU/1/09/517

    25.6.2024

    20.6.2024

    SOMAC Control

    Takeda GmbH

    Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland

    EU/1/09/516

    25.6.2024

    20.6.2024

    Spravato

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/19/1410

    24.6.2024

    20.6.2024

    Tivicay

    ViiV Healthcare BV

    Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Nederland

    EU/1/13/892

    21.6.2024

    20.6.2024

    TOBI Podhaler

    Viatris Healthcare Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

    EU/1/10/652

    21.6.2024

    20.6.2024

    Vabysmo

    Roche Registration GmbH

    Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

    EU/1/22/1683

    21.6.2024

    20.6.2024

    Voriconazole Accord

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

    EU/1/13/835

    21.6.2024

    20.6.2024

    Voriconazole Hikma

    Hikma Farmacêutica (Portugal), S.A.

    Estrada do Rio da Mó n.o 8, 8A e 8B, Fervença, 2705-906 Terrugem SNT, Portugal

    EU/1/15/1004

    28.6.2024

    20.6.2024

    Voxzogo

    BioMarin International Limited

    Shanbally, Ringaskiddy, County Cork, P43 R298, Ireland

    EU/1/21/1577

    24.6.2024

    20.6.2024

    Xaluprine

    Nova Laboratories Ireland Limited

    3rd Floor, Ulysses House, Foley Street, Dublin 1, Ireland

    EU/1/11/727

    21.6.2024

    20.6.2024

    Xerava

    PAION Deutschland GmbH

    Heussstraße 25, 52078 Aachen, Deutschland

    EU/1/18/1312

    24.6.2024

    20.6.2024

    Xtandi

    Astellas Pharma Europe B.V.

    Sylviusweg 62, 2333 BE Leiden, Nederland

    EU/1/13/846

    21.6.2024

    20.6.2024

    Zabdeno

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/20/1444

    21.6.2024

    20.6.2024

    Zyclara

    Viatris Healthcare Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

    EU/1/12/783

    24.6.2024

    20.6.2024

    Zydelig

    Gilead Sciences Ireland UC

    Carrigtohill, County Cork, T45 DP77, Ireland

    EU/1/14/938

    21.6.2024

    27.6.2024

    Byetta

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/06/362

    28.6.2024

    27.6.2024

    Levetiracetam Accord

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

    EU/1/11/712

    28.6.2024

    27.6.2024

    Mepact

    Takeda France SAS

    112 avenue Kléber, 75116 Paris, France

    EU/1/08/502

    2.7.2024

    27.6.2024

    Nucala

    GlaxoSmithKline Trading Services Limited

    Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

    EU/1/15/1043

    1.7.2024

    27.6.2024

    Rozlytrek

    Roche Registration GmbH

    Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

    EU/1/20/1460

    28.6.2024

    27.6.2024

    Stribild

    Gilead Sciences Ireland UC

    Carrigtohill, County Cork, T45 DP77, Ireland

    EU/1/13/830

    28.6.2024

    27.6.2024

    Tavneos

    Vifor Fresenius Medical Care Renal Pharma France

    100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France

    EU/1/21/1605

    28.6.2024

    27.6.2024

    Vokanamet

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/14/918

    28.6.2024

    27.6.2024

    Xospata

    Astellas Pharma Europe B.V.

    Sylviusweg 62, 2333 BE Leiden, Nederland

    EU/1/19/1399

    28.6.2024

    27.6.2024

    Zoledronic acid medac

    medac Gesellschaft für klinische Spezialpräparate mbH

    Theaterstraße 6, 22880 Wedel, Deutschland

    EU/1/12/779

    28.6.2024

    28.6.2024

    Cabazitaxel Accord

    Accord Healthcare S.L.U.

    World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

    EU/1/20/1448

    1.7.2024

    28.6.2024

    CRYSVITA

    Kyowa Kirin Holdings B.V.

    Bloemlaan 2, 2132 NP Hoofddorp, Nederland

    EU/1/17/1262

    2.7.2024

    28.6.2024

    Dovprela

    Mylan IRE Healthcare Limited

    Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

    EU/1/20/1437

    1.7.2024

    28.6.2024

    Dupixent

    Sanofi Winthrop Industrie

    82 avenue Raspail, 94250 Gentilly, France

    EU/1/17/1229

    1.7.2024

    28.6.2024

    Edistride

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/15/1052

    1.7.2024

    28.6.2024

    Emtricitabine/Tenofovir disoproxil Mylan

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1133

    1.7.2024

    28.6.2024

    Invokana

    Janssen-Cilag International NV

    Turnhoutseweg 30, 2340 Beerse, België

    EU/1/13/884

    1.7.2024

    28.6.2024

    Isturisa

    Recordati Rare Diseases

    Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

    EU/1/19/1407

    1.7.2024

    28.6.2024

    Kineret

    Swedish Orphan Biovitrum AB (publ)

    112 76 Stockholm, Sverige

    EU/1/02/203

    9.7.2024

    28.6.2024

    Livmarli

    Mirum Pharmaceuticals International B.V.

    Kingsfordweg 151, 1043 GR Amsterdam, Noord-Holland, Nederland

    EU/1/22/1704

    1.7.2024

    28.6.2024

    Matever

    Pharmathen S.A.

    6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

    EU/1/11/711

    3.7.2024

    28.6.2024

    Relvar Ellipta

    GlaxoSmithKline (Ireland) Limited

    12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

    EU/1/13/886

    1.7.2024

    28.6.2024

    Revinty Ellipta

    GlaxoSmithKline (Ireland) Limited

    12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

    EU/1/14/929

    1.7.2024

    28.6.2024

    Rotarix

    GlaxoSmithKline Biologicals S.A.

    rue de l'Institut 89, 1330 Rixensart, Belgique

    EU/1/05/330

    2.7.2024

    28.6.2024

    Supemtek

    Sanofi Pasteur

    14 Espace Henry Vallée, 69007 Lyon, France

    EU/1/20/1484

    1.7.2024

    28.6.2024

    TAGRISSO

    AstraZeneca AB

    151 85 Södertälje, Sverige

    EU/1/16/1086

    1.7.2024

    28.6.2024

    Zonisamide Mylan

    Mylan Pharmaceuticals Limited

    Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

    EU/1/16/1093

    1.7.2024

    Withdrawal of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

    Date of the decision

    Name of the medicinal product

    Holder of the marketing authorisation

    Number of the entry in the Community Register

    Date of notification

    6.6.2024

    Nityr

    Cycle Pharmaceuticals (Europe) Ltd

    70 Sir John Rogerson's Quay, Dublin 2, D02 R296, Ireland

    EU/1/18/1290

    7.6.2024

    10.6.2024

    Lymphoseek

    Navidea Biopharmaceuticals Europe Ltd.

    Kilminion South, Ballinroad, Dungarvan, Co. Waterford, X35 WP70, Ireland

    EU/1/14/955

    13.6.2024

    28.6.2024

    Pemetrexed Krka

    KRKA, d.d.

    Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

    EU/1/18/1283

    4.7.2024

    Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council; Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council): Accepted

    Date of the decision

    Name of the medicinal product

    Holder of the marketing authorisation

    Number of the entry in the Community Register

    Date of notification

    6.6.2024

    Arti-Cell Forte

    Boehringer Ingelheim Vetmedica GmbH

    D-55216 Ingelheim am Rhein, Deutschland

    EU/2/18/228

    7.6.2024

    6.6.2024

    Coxevac

    Ceva Santé Animale

    10 avenue de La Ballastière, 33500 Libourne, France

    EU/2/10/110

    7.6.2024

    6.6.2024

    Tessie

    Orion Corporation

    Orionintie 1, 02200 Espoo, Suomi

    EU/2/21/276

    7.6.2024

    13.6.2024

    Eurican Herpes 205

    Boehringer Ingelheim Vetmedica GmbH

    D-55216 Ingelheim am Rhein, Deutschland

    EU/2/01/029

    17.6.2024

    13.6.2024

    Versican Plus Pi

    Zoetis Belgium

    rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

    EU/2/14/168

    18.6.2024

    Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

    European Medicines Agency

    Domenico Scarlattilaan 6

    1083 HS Amsterdam

    NETHERLANDS


    (1)   OJ L 136, 30.4.2004, p. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.

    (2)   OJ L 4, 7.1.2019, p. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.


    ELI: http://data.europa.eu/eli/C/2024/4646/oj

    ISSN 1977-091X (electronic edition)


    Top